계정 가입
이미 존재한 계정
가입을 클릭하여 코인타임의 <a class="underline" href="#term-of-service">서비스 약관</a> 과 a class="underline" href="#privacy-policy">개인정보 보호 정책</a> . 에 동의함.
email 로 로그인
email 로 가입
사용자 이메일
수신함을 확인하세요
중의 링크를 통해 로그인 하세요
중의 링크를 통해 가입 하세요
Remix Therapeutics
company
About
Remix Therapeutics is a biotechnology company.
- 51 - 100
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- $70M
- Industries
- Biotechnology,Health Care,Medical,Therapeutics
- Founded date
- Jan 1, 2019
- Number Of Employee
- 51 - 100
- Operating Status
- Active
Remix Therapeutics is a biotechnology company that develops novel small molecule therapies designed to reprogram rna processing and treat disease in entirely new ways.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
$135M
Remix Therapeutics has raised a total of
$135M
in funding over 2 rounds. Their latest funding was raised on
May 17, 2022 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| May 17, 2022 | Series B | $70M | 1 | — | — | Detail |
| Dec 8, 2020 | Series A | $65M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Remix Therapeutics is funded by 1 investors.
ARCH Venture Partners
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
ARCH Venture Partners
|
— | Series B |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
